Where is Amolyt Pharma headquartered?

Amolyt Pharma is located in Ecully, auvergne.

Who invested in Amolyt Pharma?

Amolyt Pharma has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Amolyt Pharma?

Amolyt Pharma closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

amolytpharma.com

Amolyt Pharma

Amolyt Pharma is a France-based biotechnology company that develops and commercializes therapeutic peptides for the treatment of endocrine diseases.

Business Model:

Revenue: $4.5M

Employees: 11-50

Amolyt Pharma was acquired by Millendo Therapeutics.
The acquisition happend on 2017-12-20.
Details of the transaction were not public

Acquirer

Millendo Therapeutics

General Information

Geographic Data

Address: 15, chemin du Saquin

City: Ecully

State: auvergne

Zip: 69130

Country: FR

Financial Info

Stage:

series b

Raised Last:

$80M

Raised Total:

$173M

Social

Twitter

Crunchbase

Metrics

5,302,441Website Global Rank

1,732Website Monthly Traffic

Twitter Followers

Description

Amolyt Pharma is a France-based biotechnology company that develops and commercializes therapeutic peptides for the treatment of endocrine diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
7/2019	Series A		$0	Life Sciences Partners Kurma Partners Novo Ventures OrbiMed Partners Innovation Fund Pontifax Sham Innovation Santé Life Sciences Partners Kurma Partners Novo Ventures OrbiMed Partners Innovation Fund Pontifax Sham Innovation Santé
1/2023	Series C		$0	Turenne Capital Tekla Capital Management Sofinnova Partners Sectoral Asset Management Pontifax OrbiMed Novo Ventures Mass General Brigham Ventures Kurma Partners Intermediate Capital Group Andera Partners Andera Partners ATEM Capital Fund LP Bpifrance Credit Agricole Entreprises CTI Life Sciences Fund EQT life science ATEM Capital Fund LP Bpifrance Credit Agricole Entreprises CTI Life Sciences Fund EQT life science Turenne Capital Tekla Capital Management Sofinnova Partners Sectoral Asset Management Pontifax OrbiMed Novo Ventures Mass General Brigham Ventures Kurma Partners Intermediate Capital Group Andera Partners Andera Partners ATEM Capital Fund LP Bpifrance Credit Agricole Entreprises CTI Life Sciences Fund EQT life science ATEM Capital Fund LP Bpifrance Credit Agricole Entreprises CTI Life Sciences Fund EQT life science
9/2014	Series A	1	$6.5M	Bpifrance Bpifrance
9/2009	Venture Round	2	$4.3M	Sham Innovation Santé Octalfa Sham Innovation Santé Octalfa
5/2008	Venture Round	1	$1.7M	Octalfa Octalfa
7/2019	Series A		$75M	Lsp Novo Ventures Kurma Partners Orbimed Pontifax Turenne Capital
8/2020	Venture Round	1	-	Eurazeo Eurazeo
6/2012	Venture Round	2	$4.1M	Sham Innovation Santé Octalfa Sham Innovation Santé Octalfa
3/2015	Venture Round	5	$1.9M	Credit Agricole Entreprises Octalfa Rhone-Alpes Creation Sham Innovation Santé Sofimac Investment Managers Credit Agricole Entreprises Octalfa Rhone-Alpes Creation Sham Innovation Santé Sofimac Investment Managers
9/2021	Series B		$0	Andera Partners ATEM Capital Fund LP Bpifrance Credit Agricole Entreprises Eurazeo Kurma Partners Life Sciences Partners Mass General Brigham Ventures Novo Ventures OrbiMed Pontifax Sectoral Asset Management Sham Innovation Santé Andera Partners ATEM Capital Fund LP Bpifrance Credit Agricole Entreprises Eurazeo Kurma Partners Life Sciences Partners Mass General Brigham Ventures Novo Ventures OrbiMed Pontifax Sectoral Asset Management Sham Innovation Santé
3/2012	Venture Round		$4.1M
1/2023	Series C		$138M	Sofinnova Partners Intermediate Capital Group Tekla Capital Investment LLC CTI Life Sciences Andera Partners Novo Holdings Kurma Partners Innobio 2 Sectoral Asset Management Pontifax Orbimed Mass General Brigham Ventures ATEM Credit Agricole Creation Relyens Innovation Santé/Turenne Capital
3/2015	Venture Round		$1.9M
9/2021	Series B	13	$80M	Sectoral Asset Management Andera Partners ATEM Capital Lsp Novo Ventures Kurma Partners Mass General Brigham Ventures Innobio 2 managed by Bpifrance Orbimed Pontifax Eurazeo Sham Innovation Santé/Turenne Capital Credit Agricole Creation Andera Partners ATEM Capital Fund LP Bpifrance Credit Agricole Entreprises Eurazeo Kurma Partners Life Sciences Partners Mass General Brigham Ventures Novo Ventures OrbiMed Pontifax Sectoral Asset Management Sham Innovation Santé
8/2020	Venture Round	1	-	Eurazeo Eurazeo
7/2019	Series A	7	$74.2M	Life Sciences Partners Life Sciences Partners
3/2015	Venture Round	5	$1.9M
9/2014	Series A	1	$6.5M	Bpifrance Bpifrance
6/2012	Venture Round	2	$4.1M
9/2009	Venture Round	2	$4.3M
5/2008	Venture Round	1	$1.7M

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details